Our Team

Dr. Ajay Vishwakarma is a Harvard-trained scientist and entrepreneur committed to advancing the commercialization of cutting-edge cell and gene therapies. Before founding Cell BioEngines, he led the Cell Analysis New England Division at Agilent Technologies (NYSE: A), driving innovation in cell and gene therapy product development.

His doctoral and postdoctoral research at Harvard Medical School and MIT uncovered distinct immune cell populations and genomic signatures within tumor tissues, providing key insights into how the immune system shapes cancer progression. These discoveries also inspired the development of novel immunomodulatory cells and biomaterials designed to regulate immune cell behavior and support tissue regeneration.

Dr. Vishwakarma holds a doctorate and a master’s degree in tissue engineering and regenerative medicine from Cardiff University, UK, along with an MBA in Finance from the University of Massachusetts Boston—expertise that uniquely positions him at the intersection of science and biotechnology entrepreneurship.

He has made impactful contributions across molecular cell biology, biomaterials and tissue engineering, immune engineering, and systems biology. His work is published in leading scientific journals and recognized in authoritative textbooks on tissue engineering (with a foreword by Robert Langer) and stem cell biology (with a foreword by Hans Clevers), underscoring his influence in cancer immunotherapy and regenerative medicine.